ROTAVAC will be supplied to low income countries at $1.0/dose. New Delhi: Hyderabad-based Bharat Biotech Ltd on Wednesday announced that it had earned the World Health Organization (WHO) pre-qualification tag for its rotavirus vaccine, ROTAVAC. “We are honoured and delighted to become the first rotavirus vaccine from the developing world and India to be WHO Prequalified. We feel proud to dedicate this innovated in India and Made in India vaccine to the world. ROTAVAC will be supplied to low income countries at $1.0/dose and the company is in talks with other countries like Nigeria, Congo and other African nations which would receive the low cost vaccine.

Source: Mint January 24, 2018 19:30 UTC